Supernus Pharma (SUPN)
41.29
+0.08 (0.19%)
Upcoming Events
Latest Headlines
Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 21
October 22, 2026 6:02 AM - SEC Filing
FDA grants Supernus 7-year market exclusivity for Parkinson's drug
October 22, 2026 6:00 AM - StreetInsider
Supernus Announces Orphan Drug Exclusivity for ONAPGO™ (apomorphine HCl)
October 21, 2026 7:45 PM - StreetInsider
Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 19
October 19, 2026 4:51 PM - SEC Filing
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
October 19, 2026 8:30 AM - StreetInsider
Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 15
October 15, 2026 4:11 PM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: SUPERNUS PHARMACEUTICALS, INC.
October 6, 2026 7:16 AM - SEC Filing
Form DEFA14A SUPERNUS PHARMACEUTICALS
October 6, 2026 7:15 AM - SEC Filing
Form DEFM14A SUPERNUS PHARMACEUTICALS
September 11, 2026 4:51 PM - SEC Filing
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 2, 2026 4:30 PM - StreetInsider
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: Khattar Jack A.
August 14, 2026 5:13 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: Rubin Jonathan
August 14, 2026 5:12 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: Mottola Frank
August 14, 2026 5:12 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: Bhatt Padmanabh P.
August 14, 2026 5:12 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Aug 12 Filed by: DEC TIMOTHY C
August 14, 2026 5:10 PM - SEC Filing
Form SCHEDULE 13G/A SUPERNUS PHARMACEUTICALS Filed by: MILLENNIUM MANAGEMENT LLC
August 6, 2026 6:49 PM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: Indivior Pharmaceuticals, Inc.
August 4, 2026 6:02 AM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: Indivior Pharmaceuticals, Inc.
August 3, 2026 5:25 PM - SEC Filing
Form DEFA14A SUPERNUS PHARMACEUTICALS
August 3, 2026 5:06 PM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: SUPERNUS PHARMACEUTICALS, INC.
August 3, 2026 5:04 PM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 03
August 3, 2026 5:01 PM - SEC Filing
Form DEFA14A SUPERNUS PHARMACEUTICALS
August 3, 2026 8:37 AM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: SUPERNUS PHARMACEUTICALS, INC.
August 3, 2026 8:36 AM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 03
August 3, 2026 8:34 AM - SEC Filing
Supernus jumps premarket on merger deal; GameStop drops
August 3, 2026 8:04 AM - StreetInsider
Supernus Pharma (SUPN) Misses Q2 EPS by 144c
August 3, 2026 7:09 AM - StreetInsider
Form 10-Q SUPERNUS PHARMACEUTICALS For: Jun 30
August 3, 2026 6:56 AM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 03
August 3, 2026 6:47 AM - SEC Filing
Form DEFA14A SUPERNUS PHARMACEUTICALS
August 3, 2026 6:47 AM - SEC Filing
Form 425 SUPERNUS PHARMACEUTICALS Filed by: SUPERNUS PHARMACEUTICALS, INC.
August 3, 2026 6:46 AM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 01
August 3, 2026 6:44 AM - SEC Filing
Supernus Announces Second Quarter 2026 Financial Results
August 3, 2026 6:35 AM - StreetInsider
Supernus and Indivior agree to all-stock merger of equals
August 3, 2026 6:31 AM - StreetInsider
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
August 3, 2026 6:30 AM - StreetInsider
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: Khattar Jack A.
July 31, 2026 5:07 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: DEC TIMOTHY C
July 31, 2026 5:06 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: Mottola Frank
July 31, 2026 5:05 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: Bhatt Padmanabh P.
July 31, 2026 5:05 PM - SEC Filing
Form 4 SUPERNUS PHARMACEUTICALS For: Jul 29 Filed by: Rubin Jonathan
July 31, 2026 5:04 PM - SEC Filing
Full Article List
